
Insightful Investigations: Genetic Testing and Intermediate Severe Salla Disease
Mutations in SLC17A5 disrupt sialic acid transport, causing early onset developmental delay and neurological regression; genetic testing confirms the variant.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Mutations in SLC17A5 disrupt sialic acid transport, causing early onset developmental delay and neurological regression; genetic testing confirms the variant.

The hypothalamus fails to release enough GnRH, so puberty is delayed or absent and infertility follows; KISS1R is one gene implicated in normosmic ICH.

Skin that blisters and tears easily comes from faults in the proteins anchoring skin layers, including ITGA6; testing guides diagnosis, care and family planning.

Unlike the adult form, JALS begins in children and young adults; a sigma-1 receptor mutation has been reported, and testing informs counseling and treatment choices.

Mainly affecting adolescent boys, this benign nasopharyngeal tumor causes nasal blockage and nosebleeds; imaging, surgery and preoperative embolization are covered.

Autosomal dominant inheritance means one altered copy of SMAD4 or BMPR1A is enough; testing confirms the diagnosis, sets surveillance and identifies at-risk relatives.

Distinctive facial features, developmental delays and congenital anomalies mark Kabuki syndrome, and testing for KMT2D or KDM6A mutations can confirm the diagnosis.

Haploinsufficiency of EHMT1 on chromosome 9 underlies the intellectual disability, hypotonia, flat midface and protruding jaw seen in Kleefstra syndrome.